MedTrace Logo

The Fever and Antipyretic in Critically Illness Evaluation Study

NCT00940654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1426

Last updated 2010-05-19

No results posted yet for this study

Summary

The purpose of this multination multicenter observational study is to determine the impact of fever and antipyretic on outcomes in critically ill patients.

Conditions

Interventions

OTHER

Antipyretic therapy

External cooling;Internal cooling;Non steroid anti inflammatory drugs; Acetaminophen; Steroid

Sponsors & Collaborators

  • Japanese Society of Intensive Care Medicine

    lead OTHER

Principal Investigators

  • Younsuck Koh, M.D. PhD · Korean Society of Critical Care Medicine

  • Masaji Nishimura, M.D. PhD · Japanese Society of Intensive Care Medicine

  • Jae Yeol Kim, M.D. · Korean Society of Critical Care Medicine

  • Gee Young Suh, M.D. · Korean Society of Critical Care Medicine

  • Moritoki Egi, M.D. · Japanese Society of Intensive Care Medicine

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Japan
  • South Korea

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940654 on ClinicalTrials.gov